Concept to Clinic: Commercializing Innovation (C3i) Program

Funding Agency:
National Institutes of Health

The C3i Program is designed to provide medical device innovators with the specialized business frameworks and essential tools for successful translation of biomedical technologies from the lab (concept) to the market (clinic). Through this program, the NIH fosters the development and commercialization of early-stage biomedical technologies by engaging investigators who are interested in better understanding the value of their innovation in addressing an unmet market need. The curriculum and customized mentoring provided by the C3i Program are intended to guide investigators as they assess the commercial viability and potential business opportunity for their innovation.

Deadline: April 4, 2022

Agency Website

Eligibility Requirements


    Amount Description


      Funding Type





      Engineering and Physical Sciences
      Medical - Clinical Science
      Medical - Translational

      External Deadline

      April 4, 2022